Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • Drug Charts
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Diabetes Monitoring & Management program provides pharmacists with the skills needed to effectively advise patients and clinicians on how to use technology and pattern management to achieve improved glycemic control. Learn More.
  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs

Drugs

  • ADHD (63)
  • Agitation (1)
  • Anxiety (29)
  • Bipolar Disorder (11)
  • Depression (247)
    • Cardiovascular Disease and Depression (11)
    • Drugs (219)
      • Atypical Antipsychotics (72)
      • Benzodiazepines (44)
      • Bupropion (40)
      • MAOIs (11)
      • SNRIs (91)
      • SSRIs (133)
      • TCAs (48)
      • Typical Antipsychotics (2)
    • Natural Medicines/Supplements (9)
    • Pediatrics (16)
    • Post-Traumatic Stress Disorder (12)
    • Pregnancy (11)
    • Seasonal Affective Disorder (3)
    • Treatment-Resistant Depression (28)
  • Mental Health (23)
  • Psychology (2)
  • Resources (133)
  • Schizophrenia (54)
  • Sleep Disorders (83)
  • Substance Use Disorder (181)
151 - 165 of 219 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: You'll see ondansetron (Zofran, etc) join the list of drugs with stronger warnings about QT prolongation January 2012
Article: Abilify (aripiprazole) will be the first atypical antipsychotic approved for adolescents January 2012
Commentary: Drug Interactions With Citalopram (Celexa) January 2012
Chart: Atypical Antipsychotics in Kids January 2012
PL Voices: Anticholinergics and the Elderly December 2011
Article: The use of atypical antipsychotics is growing December 2011
Article: too many anticholinergics in an elderly patient December 2011
Article: limiting doses of citalopram (Celexa, etc) October 2011
Article: manage elderly dementia patients who have behaviour issues October 2011
Guideline: American Psychiatric Association Dementia Guideline (2011) October 2011
Commentary: Celexa (Citalopram) and QT Interval Prolongation October 2011
Article: stronger warnings about quetiapine (Seroquel, etc) and QT prolongation September 2011
Commentary: QT Prolongation, Torsades de Pointes, & Medication Safety September 2011
Guideline: Treating Tobacco Use and Dependence (2008 Update) August 2011
Commentary: Champix (Varenicline): Potential Cardiovascular Risks In Patients With Heart Disease August 2011
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved